Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Allergy Clinical Trials

A listing of Allergy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (256) clinical trials

Do you have moderate to severe Atopic Dermatitis? 

Phase

Compensation: Up to $1,950 for participation  

Phase N/A

Local doctors are looking for adults struggling with lupus for clinical research studies of an investigational medication. Doctors are studying this medication to see if it may provide relief with common symptoms associated with lupus.  

Phase N/A

B7451014 is a Phase 3 study to investigate PF-04965842 in patients aged 12 years and over with a minimum body weight of 40 kg who have moderate to severe atopic dermatitis. Subjects responding well to an initial open-label 12 week treatment of PF-04965842 (200 mg) taken orally once daily (QD) ...

Phase

“I Just Can’t Stop Scratching.” If you’ve said this to yourself before, you might qualify for a clinical study for a new investigational oral medication for the itching associated with atopic dermatitis. Atopic dermatitis patients have difficulty with a variety of symptoms including itch and excessive scratching, lesions, scaring, infection, ...

Phase N/A

A randomised, double-blind, placebo-controlled trial to evaluate the effect of tralokinumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis (AD) who are candidates for systemic therapy.  

Phase N/A

Do you or a loved one have eczema (also called "atopic dermatitis")? If so, you might be interested in a clinical study now enrolling. Wake Research is testing a study drug for eczema and we need people to take part.  

Phase N/A

Chronic itch associated with Prurigo Nodularis

Phase

This study is a 2-part (parts A and B) phase 2/3 study to evaluate the safety, pharmacokinetics (PK) and efficacy of dupilumab in patients 6 months to less than 6 years of age with severe atopic dermatitis (AD).

Phase

The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to <12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 ...

Phase